• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿素预处理对腺苷A1受体结合特性的影响。

Effects of urea pretreatment on the binding properties of adenosine A1 receptors.

作者信息

May Lauren T, Sexton Patrick M, Christopoulos Arthur

机构信息

Molecular Pharmacology Laboratory, Department of Pharmacology, The University of Melbourne, Parkville, 3010 Victoria, Australia.

出版信息

Br J Pharmacol. 2005 Dec;146(8):1119-29. doi: 10.1038/sj.bjp.0706419.

DOI:10.1038/sj.bjp.0706419
PMID:16231004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1751243/
Abstract

The effect of denaturation and/or extraction of nonintegral membrane proteins by 7 M urea on the binding of the antagonist [3H]cyclopentyl-1,3-dipropylxanthine 8 dipropyl-2,3 ([3H]DPCPX), and the agonists adenosine, (-)-N6-(2-phenylisopropyl)-adenosine (R-PIA) and N6-cyclohexyladenosine (CHA), was investigated at human A1 adenosine receptors stably expressed in CHO cells. Pretreatment with urea caused a 56% reduction in membrane proteins. Compared to controls, the use of adenosine deaminase (ADA), 100 microM 5'-guanylylimidodiphosphate (Gpp(NH)p) or urea each caused equivalent increases in specific [3H]DPCPX binding. Neither the binding kinetics nor the affinity of [3H]DPCPX were significantly different in urea-pretreated compared to ADA-pretreated membranes. At 25 degrees C in ADA-pretreated membranes, the competition isotherms for R-PIA and CHA were characterized by two affinity states. Gpp(NH)p (100 microM) reduced, but did not abolish, the value of the high-affinity dissociation constant. Similar results were obtained after treatment with urea for R-PIA, whereas the high-affinity state for CHA was abolished. At 37 degrees C, urea pretreatment, but not 100 microM Gpp(NH)p, abolished high-affinity agonist competition binding. There was no significant effect of any of the treatments on the low-affinity agonist binding state. In urea-pretreated membranes, exogenously added adenosine competed according to a simple mass-action model with a pK(L) of 5.66+/-0.05 (n=3). Compared to the more common approaches of ADA treatment and/or use of guanine nucleotides, our findings suggest that urea pretreatment represents an inexpensive and useful approach for investigating the binding properties of adenosine A1 ligands (including adenosine) to the G protein-uncoupled form of the receptor.

摘要

研究了7M尿素对非整合膜蛋白的变性和/或提取作用,对稳定表达于CHO细胞中的人A1腺苷受体上拮抗剂[3H]环戊基-1,3-二丙基黄嘌呤8-二丙基-2,3([3H]DPCPX)以及激动剂腺苷、(-)-N6-(2-苯异丙基)-腺苷(R-PIA)和N6-环己基腺苷(CHA)结合的影响。用尿素预处理导致膜蛋白减少56%。与对照组相比,使用腺苷脱氨酶(ADA)、100μM 5'-鸟苷酰亚胺二磷酸(Gpp(NH)p)或尿素均使特异性[3H]DPCPX结合等量增加。与ADA预处理的膜相比,尿素预处理的膜中[3H]DPCPX的结合动力学和亲和力均无显著差异。在25℃下,ADA预处理的膜中,R-PIA和CHA的竞争等温线具有两种亲和力状态。Gpp(NH)p(100μM)降低但未消除高亲和力解离常数的值。用尿素处理R-PIA后得到类似结果,而CHA的高亲和力状态被消除。在37℃下,尿素预处理而非100μM Gpp(NH)p消除了高亲和力激动剂竞争结合。任何处理对低亲和力激动剂结合状态均无显著影响。在尿素预处理的膜中,外源添加的腺苷根据简单质量作用模型进行竞争,pK(L)为5.66±0.05(n = 3)。与更常用的ADA处理和/或使用鸟嘌呤核苷酸的方法相比,我们的研究结果表明,尿素预处理是一种用于研究腺苷A1配体(包括腺苷)与G蛋白非偶联形式受体结合特性的廉价且有用的方法。

相似文献

1
Effects of urea pretreatment on the binding properties of adenosine A1 receptors.尿素预处理对腺苷A1受体结合特性的影响。
Br J Pharmacol. 2005 Dec;146(8):1119-29. doi: 10.1038/sj.bjp.0706419.
2
Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.MgCl₂ 和 Gpp(NH)p 对拮抗剂和激动剂放射性配体与腺苷 A1 受体结合的影响比较。
Acta Pharmacol Sin. 2003 Aug;24(8):729-40.
3
The effects of saponin on the binding and functional properties of the human adenosine A1 receptor.皂苷对人腺苷A1受体结合及功能特性的影响。
Br J Pharmacol. 1996 Apr;117(7):1521-9. doi: 10.1111/j.1476-5381.1996.tb15316.x.
4
Modulating effect of adenosine deaminase on function of adenosine A1 receptors.腺苷脱氨酶对腺苷A1受体功能的调节作用。
Acta Pharmacol Sin. 2005 Feb;26(2):160-5. doi: 10.1111/j.1745-7254.2005.00524.x.
5
Characteristics of an adenosine A1 binding site in human placental membranes.人胎盘膜中腺苷A1结合位点的特征
Arch Biochem Biophys. 1989 Jan;268(1):191-202. doi: 10.1016/0003-9861(89)90579-1.
6
Characterization of a low affinity binding site for N6-substituted adenosine derivatives in rat testis membranes.大鼠睾丸膜中N6-取代腺苷衍生物低亲和力结合位点的特性研究。
J Recept Signal Transduct Res. 1995 Sep-Dec;15(7-8):905-29. doi: 10.3109/10799899509049864.
7
Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.完整DDT1 MF-2平滑肌细胞中腺苷A1受体的特性研究
Mol Pharmacol. 1990 Nov;38(5):660-6.
8
Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.鸟嘌呤核苷酸对激动剂和拮抗剂与A1腺苷受体结合的相互调节是通过一种百日咳毒素敏感的G蛋白介导的。
J Pharmacol Exp Ther. 1988 Sep;246(3):1194-200.
9
Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.基于黄嘌呤和吡唑并吡啶的拮抗剂揭示的脑腺苷A1受体药理学中的物种差异。
Br J Pharmacol. 1997 Nov;122(6):1202-8. doi: 10.1038/sj.bjp.0701465.
10
Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.一种腺苷受体的分子克隆与特性分析:A3腺苷受体
Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7432-6. doi: 10.1073/pnas.89.16.7432.

引用本文的文献

1
Identification of a Lipid-Exposed Extrahelical Binding Site for Positive Allosteric Modulators of the Dopamine D Receptor.鉴定多巴胺D受体正变构调节剂的脂质暴露螺旋外结合位点
ACS Chem Neurosci. 2025 Jun 18;16(12):2295-2311. doi: 10.1021/acschemneuro.5c00105. Epub 2025 May 15.
2
Polyamine: A Potent Ameliorator for Plant Growth Response and Adaption to Abiotic Stresses Particularly the Ammonium Stress Antagonized by Urea.多胺:一种促进植物生长反应和适应非生物胁迫(尤其是尿素拮抗铵胁迫)的有效改良剂。
Front Plant Sci. 2022 Mar 23;13:783597. doi: 10.3389/fpls.2022.783597. eCollection 2022.
3
Minute-scale persistence of a GPCR conformation state triggered by non-cognate G protein interactions primes signaling.非同源 G 蛋白相互作用触发的 GPCR 构象状态的分钟级持续时间为信号转导做好准备。
Nat Commun. 2019 Oct 23;10(1):4836. doi: 10.1038/s41467-019-12755-9.
4
Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor.细胞外环 II 调节前列腺素 EP3 受体的 GTP 敏感性。
Mol Pharmacol. 2013 Jan;83(1):206-16. doi: 10.1124/mol.112.080473. Epub 2012 Oct 18.
5
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.国际基础和临床药理学联合会. LXXXI. 腺苷受体的命名和分类-更新。
Pharmacol Rev. 2011 Mar;63(1):1-34. doi: 10.1124/pr.110.003285. Epub 2011 Feb 8.
6
Molecular mechanisms of action and in vivo validation of an M4 muscarinic acetylcholine receptor allosteric modulator with potential antipsychotic properties.M4 毒蕈碱型乙酰胆碱受体变构调节剂的作用机制及其体内验证,具有潜在的抗精神病特性。
Neuropsychopharmacology. 2010 Mar;35(4):855-69. doi: 10.1038/npp.2009.194. Epub 2009 Nov 25.
7
Determination of adenosine A1 receptor agonist and antagonist pharmacology using Saccharomyces cerevisiae: implications for ligand screening and functional selectivity.利用酿酒酵母测定腺苷A1受体激动剂和拮抗剂药理学:对配体筛选和功能选择性的影响。
J Pharmacol Exp Ther. 2009 Oct;331(1):277-86. doi: 10.1124/jpet.109.158667. Epub 2009 Jul 29.

本文引用的文献

1
Comparison of effects of MgCl2 and Gpp(NH)p on antagonist and agonist radioligand binding to adenosine A1 receptors.MgCl₂ 和 Gpp(NH)p 对拮抗剂和激动剂放射性配体与腺苷 A1 受体结合的影响比较。
Acta Pharmacol Sin. 2003 Aug;24(8):729-40.
2
Allosteric adenosine receptor modulation reduces hypersensitivity following peripheral inflammation by a central mechanism.变构腺苷受体调节通过中枢机制减轻外周炎症后的超敏反应。
J Pharmacol Exp Ther. 2003 Jun;305(3):950-5. doi: 10.1124/jpet.102.047951. Epub 2003 Feb 20.
3
Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain.在神经性疼痛大鼠模型中,脊髓去甲肾上腺素能激活介导变构腺苷调节剂减轻痛觉过敏。
Pain. 2002 May;97(1-2):117-25. doi: 10.1016/s0304-3959(02)00011-8.
4
2-Amino-3-aroyl-4,5-alkylthiophenes: agonist allosteric enhancers at human A(1) adenosine receptors.2-氨基-3-芳酰基-4,5-烷基噻吩:人A(1)腺苷受体的变构激动增强剂。
J Med Chem. 2002 Jan 17;45(2):382-9. doi: 10.1021/jm010081p.
5
Allosteric adenosine modulation to reduce allodynia.变构腺苷调节以减轻异常性疼痛。
Anesthesiology. 2001 Aug;95(2):416-20. doi: 10.1097/00000542-200108000-00025.
6
Selective inactivation of guanine-nucleotide-binding regulatory protein (G-protein) alpha and betagamma subunits by urea.通过尿素对鸟嘌呤核苷酸结合调节蛋白(G蛋白)α亚基和βγ亚基进行选择性失活。
Biochem J. 2001 Mar 1;354(Pt 2):337-44. doi: 10.1042/0264-6021:3540337.
7
Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor.变构增强剂(2-氨基-4,5-二甲基-三烯基)[3-(三氟甲基)苯基]甲酮(PD81,723)对人野生型和突变型(T277A)腺苷A1受体激动剂和拮抗剂结合及功能的差异作用。
Biochem Pharmacol. 2001 Jan 15;61(2):137-44. doi: 10.1016/s0006-2952(00)00536-0.
8
Functions of neuronal adenosine receptors.神经元腺苷受体的功能。
Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):375-81. doi: 10.1007/s002100000314.
9
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor.新型2-氨基-3-苯甲酰基噻吩系列作为A1-腺苷受体变构增强剂的合成及生物学效应
Bioorg Med Chem Lett. 2000 Sep 4;10(17):1953-7. doi: 10.1016/s0960-894x(00)00379-6.
10
Plant heterotrimeric G protein beta subunit is associated with membranes via protein interactions involving coiled-coil formation.植物异源三聚体G蛋白β亚基通过涉及卷曲螺旋形成的蛋白质相互作用与膜相关联。
FEBS Lett. 2000 Jul 7;476(3):208-12. doi: 10.1016/s0014-5793(00)01706-3.